Synthesis of novel texaphyrins containing lanthanides and boron

Tetrahedron Letters

Volumn 48, Issue 26, 2007, Pages 4467-4469

  Bandyopadhyaya, Achintya K ^a   Narayanasamy, Sureshbabu ^a   Barth, Rolf F ^a,b   Tjarks, Werner ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Boronated gadolinium and lutetium texaphyrins (GdB and LuB texaphyrins); Carboranyl pyrroles; Gadolinium and boron neutron capture therapy (GdB NCT)

Indexed keywords

BORON; CARBORANE DERIVATIVE; GADOLINIUM; GADOLINIUM TEXAPHYRIN; HETEROCYCLIC COMPOUND; LANTHANIDE; LUTETIUM; LUTETIUM TEXAPHYRIN; MACROCYCLIC COMPOUND; PYRROLE DERIVATIVE; TEXAPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; NEUTRON CAPTURE THERAPY; SYNTHESIS;

EID: 34249276328     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.04.149     Document Type: Article

References (29)

1. Magda D., and Miller R.A. Sem. Cancer. Biol. 16 (2006) 466
2. Yeung, P. K. F. Pharmacyclics. IDrugs, 2001, 4, 351.
3. Sessler, J. L.; Allen, W. E.; Kral, V. A. U.S. Patent 5,955,586 A, 1999.
4. Mody, T. D.; Sessler, J. L.; Young, W. U.S. Patent 2,92,072, 2006.
5. Salt C., Lennox A.J., Takagaki M., Maguire J.A., and Hosmane N.S. Russ. Chem. Bull. 53 (2004) 1871
6. Barth R.F., Coderre J.A., Vicente M.G.H., and Blue T.E. Clin. Cancer Res. 11 (2005) 3987
7. Pouget J.-P., and Mather S.J. Eur. J. Nucl. Med. 28 (2001) 541
8. Le U.M., and Cui Z. Int. J. Pharm. 320 (2006) 96
9. Oyewumi M.O., Yokel R.A., Jay M., Coakley T., and Mumper R.J. J. Controlled Release. 95 (2004) 613
10. Goorley T., and Nikjoo H. Radiat. Res. 154 (2000) 556
11. Miller Jr. G.A., Hertel N.E., Wehring B.W., and Horton J.L. Nucl. Technol. 103 (1993) 320
12. Goorley T., Zamenhof R., and Nikjoo H. Int. J. Radiat. Biol. 80 (2004) 933
13. Mody T.D., Fu L., and Sessler J.L. Prog. Inorg. Chem. 49 (2001) 551
14. Narayanasamy S., Thirumamagal B.T.S., Johnsamuel J., Byun Y., Al-Madhoun A.S., Usova E., Cosquer G.Y., Yan J., Bandyopadhyaya A.K., Tiwari R., Eriksson S., and Tjarks W. Bioorg. Med. Chem. 14 (2006) 6886
15. Hiom J., Paine J.B., Zapf U., and Dolphin D. Can. J. Chem. 61 (1983) 2220
16. Shevchuk S.V., Davis J.M., and Sessler J.L. Tetrahedron Lett. 42 (2001) 2447
17. Sessler J.L., Mody T.D., Hemmi G.W., and Lynch V. Inorg. Chem. 32 (1993) 3175
18. Sessler J.L., Johnson R.M., and Lynch V. J. Org. Chem. 52 (1987) 4394
19. Clezy P.S., Fookes C.J.R., and Liepa A.J. Aust. J. Chem. 25 (1972) 1979
20. Sessler J.L., Hemmi G., Mody T.D., Murai T., Burrell A., and Young S.W. Acc. Chem. Res. 27 (1994) 43
21. Magda, D.; Sessler, J. L.; Hanna, S. U.S. Patent 6,657,058, B1, 1999.
22. Wei W.-H., Wang Z., Mizuno T., Cortez C., Fu L., Sirisawad M., Naumovski L., Magda D., and Sessler J.L. Dalt. Trans. 16 (2006) 1934
23. + calcd 1016.6084; found 1016.6122. For compounds 1, 2, 3, 9, and 10, the value of the most abundant peak of the isotope pattern is reported as HR signal.
24. Miles D., Mody T.D., Hatcher L.I., Fiene J., Stiles M., Lin P.P., and Lee J.W. AAPS Pharm. Sci. 5 (2003) 231
25. Wang Z., Fu L., and Mody D.T. Chem. Commun. (2002) 678
26. Lisowski J., Sessler J.L., and Mody T.D. Inorg. Chem. 34 (1995) 4336
27. Lisowski J., Sessler J.L., Lynch V., and Mody T.D. J. Am. Chem. Soc. 117 (1995) 2273
28. Wu G., Yang W., Barth R.F., Kawabata S., Swindall M., Bandyopadhyaya A.K., Tjarks W., Khorsandi B., Blue T.E., Ferketich A.K., Yang M., Christoforidis G.A., Sferra T.J., Binns P.J., Riley K.J., Ciesielski M.J., and Fenstermaker R.A. Clin. Cancer Res. 13 (2007) 1260
29. Kobayashi H., and Brechbiel M.W. Adv. Drug Delivery Rev. 57 (2005) 2271